15% of all profit is donated to Heal Palestine and the Palestine Children's Relief Fund (PCRF)
Platform Research Validation Safety Pricing Company Demo Request access
Prospect-1

Drug discovery that starts from the biology.

Prospect-1 is a transparent, safety-gated research pipeline: it selects a target from the genetics, designs candidate molecules, and screens them through ADMET, docking, and physics-based rescoring. Every result is a research hypothesis for a wet lab, never a validated drug.

The pipeline

From a target to a testable hypothesis

One path, with two gates that cannot be skipped. Nothing leaves the pipeline without passing a biosecurity screen and a human sign-off.

Screening pipelineresearch use only
Target Design Screen Biosecurity non-negotiable Human check PI sign-off in silico safety gates

A research hypothesis for a wet lab, never a validated drug and never a synthesis instruction. Prospect-1 flags its own compute limits instead of estimating missing values, and abstains rather than guess.

How it is built

Honest by construction

Data integrity first

When the compute or the data cannot support a value, Prospect-1 says so and abstains, rather than filling the gap with an estimate that looks confident and is not.

Biosecurity is not optional

A non-overridable screen runs before anything advances, and Prospect-1 never emits synthesis routes for hazardous chemistry. Safety is a gate in the pipeline, not a setting.

A human closes the loop

Every candidate is a hypothesis handed to a qualified researcher for validation. No result is a recommendation, and nothing reaches a bench without a person deciding it should.